Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease Receiving Donepezil, Memantine or Donepezil/Memantine Combination Therapy: Open-Labeled, Randomized, Phase IV, Superiority Study

Neutec Ar-Ge San ve Tic A.Ş1 site in 1 country198 target enrollmentOctober 15, 2020

ConditionsAlzheimer Disease Cognitive Change

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: Alzheimer Disease
Sponsor: Neutec Ar-Ge San ve Tic A.Ş
Enrollment: 198
Locations: 1
Primary Endpoint: Change in MOCA total score
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

In this study, it is aimed to compare the effects of cognitive exercises applied on long-term internet environment to the cognitive level of patients who received donepezil, memantine or donepezil / memantin combination therapy.

Registry

clinicaltrials.gov

Start Date

October 15, 2020

End Date

March 1, 2024

Last Updated

3 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Neutec Ar-Ge San ve Tic A.Ş

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients between 55-90 years old who were diagnosed with Alzheimer's Dementia and had no history of cerebrovascular disease during the last 6 months,
•Patients without other neurodegenerative diseases and secondary dementia diagnoses,
•Patients with MOCA score of between 13-18,
•Patients with at least primary school graduation,
•Patients who have had no CNS disease including trauma in the last year,
•Patients without a diagnosis of psychiatric disease,
•Patients with a tablet or PC with an internet connection,
•Patients agreeing to perform BEYNEX daily activity at least 5 times per week,
•Patients signing informed consent form.